review article | Q7318358 |
scholarly article | Q13442814 |
P356 | DOI | 10.1016/J.JACC.2019.07.061 |
P698 | PubMed publication ID | 31537270 |
P2093 | author name string | Peter Libby | |
Göran K Hansson | |||
P2860 | cites work | Identification of splenic reservoir monocytes and their deployment to inflammatory sites | Q24649151 |
Regulation of an inflammatory disease: Krüppel-like factors and atherosclerosis | Q26852339 | ||
Biomechanics of vascular mechanosensation and remodeling | Q28067208 | ||
A century of cholesterol and coronaries: from plaques to genes to statins | Q28080618 | ||
Age-related clonal hematopoiesis associated with adverse outcomes | Q28386602 | ||
Vascular endothelial growth factor is a secreted angiogenic mitogen | Q28646475 | ||
Inflammation, atherosclerosis, and coronary artery disease | Q29547232 | ||
The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine | Q29547539 | ||
Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein | Q29547752 | ||
Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men | Q29619308 | ||
Vascular Smooth Muscle Cells in Atherosclerosis | Q30277316 | ||
Atherosclerosis research from past to present--on the track of two pathologists with opposing views, Carl von Rokitansky and Rudolf Virchow | Q33239820 | ||
The pathogenesis of atherosclerosis (first of two parts) | Q33492794 | ||
Atherosclerosis and the arterial smooth muscle cell: Proliferation of smooth muscle is a key event in the genesis of the lesions of atherosclerosis | Q34207431 | ||
Classics in arteriosclerosis research: On experimental cholesterin steatosis and its significance in the origin of some pathological processes by N. Anitschkow and S. Chalatow, translated by Mary Z. Pelias, 1913 | Q70249421 | ||
Studies of hypercholesterolemia in the nonhuman primate. I. Changes that lead to fatty streak formation | Q70580552 | ||
Changes in the endothelium of the aorta and the behaviour of macrophages in experimental atheroma of rabbits | Q78335068 | ||
Thrombosis as a factor in the pathogenesis of coronary atherosclerosis | Q82176732 | ||
Never Waste a Good Crisis: Confronting Reproducibility in Translational Research | Q88328407 | ||
Low-Grade Inflammation in the Association between Mild-to-Moderate Hypertriglyceridemia and Risk of Acute Pancreatitis: A Study of More Than 115000 Individuals from the General Population | Q90287214 | ||
JAK2-V617F promotes venous thrombosis through β1/β2 integrin activation | Q90340948 | ||
Macrophage Inflammation, Erythrophagocytosis, and Accelerated Atherosclerosis in Jak2 V617F Mice | Q90668200 | ||
Colchicine in Cardiovascular Disease: Repurposing an Ancient Gout Drug | Q90803840 | ||
Chemokines as Therapeutic Targets in Cardiovascular Disease | Q91552719 | ||
Sleep modulates haematopoiesis and protects against atherosclerosis | Q91560031 | ||
Immunotherapy for cardiovascular disease | Q92241512 | ||
Single-Cell Analysis of the Normal Mouse Aorta Reveals Functionally Distinct Endothelial Cell Populations | Q92410796 | ||
Targeting the Immune System in Atherosclerosis: JACC State-of-the-Art Review | Q92855989 | ||
Low-Dose Methotrexate for the Prevention of Atherosclerotic Events | Q92980641 | ||
Has the time finally come to measure hsCRP universally in primary and secondary cardiovascular prevention? | Q93211515 | ||
From studies of biochemical mechanism to novel biological mediators: Prostaglandin endoperoxides, thromboxanes, and leukotriences | Q34255111 | ||
Pathophysiology of coronary artery disease | Q34429470 | ||
Factors of risk in the development of coronary heart disease--six year follow-up experience. The Framingham Study | Q34539702 | ||
Expression of class II transplantation antigen on vascular smooth muscle cells in human atherosclerosis | Q34541589 | ||
Clonal hematopoiesis associated with TET2 deficiency accelerates atherosclerosis development in mice | Q34549707 | ||
Clonal Hematopoiesis and Risk of Atherosclerotic Cardiovascular Disease. | Q34558126 | ||
Common genetic loci influencing plasma homocysteine concentrations and their effect on risk of coronary artery disease | Q35062523 | ||
Evidence for a Monoclonal Origin of Human Atherosclerotic Plaques | Q35105935 | ||
Rapid monocyte kinetics in acute myocardial infarction are sustained by extramedullary monocytopoiesis | Q35679591 | ||
The role of the monocyte in atherogenesis: I. Transition of blood-borne monocytes into foam cells in fatty lesions | Q35864063 | ||
Adaptive Response of T and B Cells in Atherosclerosis | Q35928023 | ||
Vascular endothelium, hemodynamics, and the pathobiology of atherosclerosis | Q36041802 | ||
Endothelial Cell Dysfunction and the Pathobiology of Atherosclerosis | Q36602763 | ||
Leukocytes Link Local and Systemic Inflammation in Ischemic Cardiovascular Disease: An Expanded "Cardiovascular Continuum". | Q36654171 | ||
Intertwining of thrombosis and inflammation in atherosclerosis | Q36667645 | ||
Local proliferation dominates lesional macrophage accumulation in atherosclerosis | Q37161176 | ||
Discovery of the role of wall shear in atherosclerosis | Q37336484 | ||
Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease | Q38606033 | ||
Trained immunity: A program of innate immune memory in health and disease. | Q38814347 | ||
A guiding map for inflammation | Q40128384 | ||
The pathogenesis of atherosclerosis (second of two parts) | Q40547842 | ||
Paradoxical vasoconstriction induced by acetylcholine in atherosclerotic coronary arteries | Q41381379 | ||
Endotoxin and tumor necrosis factor induce interleukin-1 gene expression in adult human vascular endothelial cells | Q42752391 | ||
Oxidized low-density lipoprotein and atherosclerosis | Q43816762 | ||
Simian Sarcoma Virus onc Gene, v- sis , Is Derived from the Gene (or Genes) Encoding a Platelet-Derived Growth Factor | Q45798365 | ||
Low-dose colchicine for secondary prevention of cardiovascular disease | Q46245044 | ||
Murine "model" monotheism: an iconoclast at the altar of mouse | Q46643118 | ||
Interleukin-1 Beta as a Target for Atherosclerosis Therapy: Biological Basis of CANTOS and Beyond | Q47599422 | ||
NHLBI Working Group Recommendations to Reduce Lipoprotein(a)-Mediated Risk of Cardiovascular Disease and Aortic Stenosis. | Q50081201 | ||
Atlas of the Immune Cell Repertoire in Mouse Atherosclerosis Defined by Single-Cell RNA-Sequencing and Mass Cytometry. | Q52653300 | ||
Single-Cell RNA-Seq Reveals the Transcriptional Landscape and Heterogeneity of Aortic Macrophages in Murine Atherosclerosis. | Q52653301 | ||
Increased neutrophil extracellular trap formation promotes thrombosis in myeloproliferative neoplasms. | Q52719979 | ||
Inflammation, Immunity, and Infection in Atherothrombosis: JACC Review Topic of the Week | Q57797462 | ||
Rationale and design of the Pemafibrate to Reduce Cardiovascular Outcomes by Reducing Triglycerides in Patients with Diabetes (PROMINENT) study | Q57820905 | ||
CHIP (Clonal Hematopoiesis of Indeterminate Potential) | Q57823938 | ||
Natural regulatory T cells control the development of atherosclerosis in mice | Q58149268 | ||
The Prognostic Value of C-Reactive Protein and Serum Amyloid A Protein in Severe Unstable Angina | Q58230388 | ||
Macrophage Trafficking, Inflammatory Resolution, and Genomics in Atherosclerosis: JACC Macrophage in CVD Series (Part 2) | Q58592678 | ||
Low-dose interleukin-2 in patients with stable ischaemic heart disease and acute coronary syndromes (LILACS): protocol and study rationale for a randomised, double-blind, placebo-controlled, phase I/II clinical trial | Q58732372 | ||
Low-Density Lipoprotein-Reactive T Cells Regulate Plasma Cholesterol Levels and Development of Atherosclerosis in Humanized Hypercholesterolemic Mice. | Q64915291 | ||
Thrombin potently stimulates cytokine production in human vascular smooth muscle cells but not in mononuclear phagocytes. | Q64997505 | ||
Angiogenic factors: regulators of blood supply-side biology. FGF, endothelial cell growth factors and angiogenesis: a keystone symposium, Keystone, CO, USA, April 1-7, 1991 | Q67702489 | ||
Regional accumulations of T cells, macrophages, and smooth muscle cells in the human atherosclerotic plaque | Q69990504 | ||
P433 | issue | 12 | |
P921 | main subject | systemic inflammation | Q7663815 |
P304 | page(s) | 1594-1607 | |
P577 | publication date | 2019-09-01 | |
P1433 | published in | Journal of the American College of Cardiology | Q2984355 |
P1476 | title | From Focal Lipid Storage to Systemic Inflammation: JACC Review Topic of the Week | |
P478 | volume | 74 |
Q92931292 | ANGPTL3, PCSK9, and statin therapy drive remarkable reductions in hyperlipidemia and atherosclerosis in a mouse model |
Q90460683 | Cholesterol versus Inflammation as Cause of Chronic Diseases |
Q112744936 | Cysteamine Decreases Low-Density Lipoprotein Oxidation, Causes Regression of Atherosclerosis, and Improves Liver and Muscle Function in Low-Density Lipoprotein Receptor-Deficient Mice |
Q104134981 | Mild hyperlipidemia in mice aggravates platelet responsiveness in thrombus formation and exploration of platelet proteome and lipidome |